ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1993

Impact of Metabolic Syndrome on Ultrasonographic Findings and Quality of Life in Patients with Early Osteoarthritis

Maria Fernanda Gonzalez-Hernandez1, Rolando Espinosa-Morales2, Carlos Pineda2, Angelica Peña3, Araceli Bernal1 and Alejandra Alabarda1, 1Instituto Nacional de Rehabilitación "Luis Guillermo Ibarra Ibarra", Mexico City, Mexico, 2Instituto Nacional de Rehabilitacion, Mexico City, Mexico, 3Instituto Mexicano del Seguro Social, Querétaro, Mexico

Meeting: ACR Convergence 2023

Keywords: metabolic syndrome, Osteoarthritis, quality of life, Ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: (1977–1995) Osteoarthritis – Clinical Poster III

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Osteoarthritis (OA) is a common disorder with increased incidence with age. Metabolic syndrome (MS) is frequently associated with OA, although other factors are considered the primary cause of the development of OA, such as: genetic, inflammatory, neuroendocrine, and mechanical stress. Conventional radiography (CR) is used to diagnose the changes of knee OA (KOA) (joint space, osteophytes, sclerosis); however early changes are difficult to assess, and few articles report these abnormalities. Previous research demonstrated a higher sensibility in ultrasonography (US) in detecting early abnormalities compared to CR in early knee OA (eKOA). The objective of this study is to estimate the impact of metabolic syndrome in relation to prevalence of US findings and quality of life in patients with eKOA.

Methods: We included patients with eKOA diagnosis from out-patients clinical of rheumatology department, eKOA was describe as grade I and II by Kellgren and Lawrence scale. We evaluated for presence of metabolic syndrome based of ATP-III. Using a structured clinical questionnaire, we recorded epidemiologic data. Quality of life and joint functionality was evaluated with Lequesne index, EQ-5D and WOMAC. Patients were divided in two groups: eKOA with and without MS. An US was performed in each patient, structural changes in eKOA we evaluated was based in the OMERACT definitions. The structures evaluated include medial superior and lateral recess, anserine and infrapatellar bursitis, medial and lateral meniscus extrusion were scanned in each knee.

Statistical Analysis. Descriptive analysis of variables was done. In order to compare two variables, we used bivariate analysis, using t-student, Wilcoxon test, chi2

Results: We include 154 patients, female 132 patients (85.7%) vs. 22 men (14.3%). 51 (33%) patients with MS vs. 108 (67 %) without MS; of MS patients there were 9 (41%) men vs. 42 (59%) women (p=0.402). Median age of females was 47.03 ± 6.85 vs. 46 ± 7.43 in males (p=0.519). The patient with MS realized less physical activity compared with patients without MS. 78.2 % without MS vs. 21.8% (p=0.02). The patient with MS reported some comorbidities: Diabetes Mellitus 38.46%, hypertension 42.1%, hypothyroidism 7.69% and others 13.73% vs patients without MS: Diabetes Mellitus 10.71%, hypertension 17.86 %, dyslipidemia 7.14, venous insufficiency 46.43%, other 17.86 (p=0.003). We found statistical significance in the metabolic syndrome group finding synovitis in medial superior recess of the right knee (p =0.031) and Doppler activity in lateral recess of right knee (p=0.05), without significance in the presence of osteophytes. Quality of life and functionality we did not find statistical significance. (Table 1)

Conclusion: Patients with eKOA have a good QofL. The ultrasound could have an important role in eKOA to find risk factors of progression and phenotypes. There are increased prevalence of risk factors in MS patients.

Supporting image 1

Ultrasound findings on metabolic syndrome and OA patients


Disclosures: M. Gonzalez-Hernandez: None; R. Espinosa-Morales: None; C. Pineda: None; A. Peña: None; A. Bernal: None; A. Alabarda: None.

To cite this abstract in AMA style:

Gonzalez-Hernandez M, Espinosa-Morales R, Pineda C, Peña A, Bernal A, Alabarda A. Impact of Metabolic Syndrome on Ultrasonographic Findings and Quality of Life in Patients with Early Osteoarthritis [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/impact-of-metabolic-syndrome-on-ultrasonographic-findings-and-quality-of-life-in-patients-with-early-osteoarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/impact-of-metabolic-syndrome-on-ultrasonographic-findings-and-quality-of-life-in-patients-with-early-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology